The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Ra Pharmaceuticals competitive analysis

Loading summary...

Latest oppositions filed by Ra Pharmaceuticals

Explore patent oppositions filed by Ra Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3632907
N-(Azaaryl)Cyclolactam-1-Carboxamide Derivative, Preparation Method Therefor, And Use ThereofABBISKO THERAPEUTICSNov 13, 2024

Latest patents of Ra Pharmaceuticals opposed by its competitors

Explore Ra Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3980047
Feb 14, 2024Inflammatory Disease Treatment With Complement Inhibitors1

Latest PTAB cases involving Ra Pharmaceuticals

Discover the latest PTAB cases involving Ra Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ra Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
DECIPHERA PHARMACEUTICALS12 - -
ABBISKO THERAPEUTICS - 1 - -
ALFRED E TIEFENBACHER443 - -